According to the KLAS report Clinical Market Share 2013: More than Meaningful Use, Cerner Corporation and Epic Systems combined captured more than three-fourths of new large-hospital electronic medical records (EMR) contracts, while the other vendors struggled to keep pace.
Accuray Incorporated announced that studies presented at the American Society for Radiation Oncology (ASTRO) 55th Annual Meeting continue to reinforce evidence of clinical and quality of life benefits for the CyberKnife and TomoTherapy Systems.
The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services (CMS) decision to allow only Coverage with Evidence Development (CED) for an Alzheimer's imaging test that would improve diagnostic accuracy and certainty in challenging cases. When used in specific populations, as outlined in criteria developed by the Alzheimer's Association and the Society for Nuclear Medicine and Molecular Imaging (SNMMI), this tool has the potential to help identify amyloid in the brain, a hallmark of Alzheimer's disease, and resolve distressing medical uncertainty.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
Immediate U.S. government furloughs affecting virtually all National Science Foundation (NSF) employees and three-fourths of those at the National Institutes of Health (NIH) could impact U.S. competitiveness, American Association for the Advancement of Science (AAAS) warned.
The Arthritis Foundation awarded $1 million to the Hospital for Special Surgery in New York City, University of California-San Francisco (UCSF) and Mayo Clinic in Rochester, Minn. to validate the use of new magnetic resonance imaging (MRI) techniques and newly identified biomarkers.

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Esteya, an electronic brachytherapy system, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), enabling medical centers in the United States to offer their patients with skin cancer a new treatment option.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
Smarter study comparisons, new modality activity/cost management reports and an enhanced interface comprise NovaRad’s NovaRIS/NovaPACS combined radiology system upgrades.
At RSNA 2013, GE Healthcare will showcase a range of molecular imaging tools designed to enable treatment evaluation earlier in a patient’s care pathway. Q.Suite, a collection of capabilities designed to extend quantitative positron emission tomography (PET) by generating more consistent standardized uptake value (SUV) readings, enabling clinicians to assess treatment response. Q.Suite is designed to help improve consistency of quantitative measurements in every key area: daily quality control, scanner workflow, motion correction, reconstruction algorithms and analysis and reporting applications. Controlling these variables to increase consistency can improve the clinician’s confidence that an SUV change has useful clinical meaning.
At RSNA 2013, GE will continue to demonstrate its innovations in low dose and high image quality in computed tomography (CT) imaging. The Discovery CT750 HD is the world's first high definition CT (HDCT), built with GE's exclusive Gemstone detector FREEdom Technologies. This allows for intelligent motion correction to “freeze” coronary motion, enhance coronary visualization and obtain additional information on plaque material composition. New this year is kV Assist, which provides optimized personalized scan settings and applications with automated kV and mA selection. kV Assist combined with SnapShot Assist deliver the desired image quality at the lowest possible dose and workflow optimizations for efficient cardiac CT.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
When echocardiograms prove insufficient for diagnosis, Diagnosoft’s offers a patented and U.S. Food and Drug Administration 510(k)-cleared cardiac magnetic resonance imaging (CMR) solution for patient assessment. With benchmark sensitivity and specificity, the high throughput Diagnosoft CMR exam yields an advantageous alternative to nuclear or cardiac cath exams.
Independent global research organization Frost & Sullivan honored Barco, a healthcare imaging solutions company, with the 2013 North American Product Line Strategy Award in Diagnostic Imaging Displays at the 2013 Growth, Innovation & Leadership Awards on Sept. 9, 2013 in San Jose, Calif. The award recognized Barco for delivering excellence and best practices in the North American diagnostic image displays market.
Konica Minolta Medical Imaging announced the U.S. Food and Drug Administration (FDA) has cleared the Aero DR 10 x 12 wireless plate for sale. This plate is for sites seeking a smaller and lighter wireless flat panel for use in general X-ray and specialty applications such as orthopedics and pediatrics. This includes the neonatal intensive care unit (NICU), where the Aero DR 10 x 12 detector fits most basinets and can be used with all major portable X-ray systems from various manufacturers.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Philips Speech Processing Solutions announced it will partner with ZyDoc, a medical transcription, speech recognition and natural language processing (NLP) technologies integrator, to continue to provide advances in voice productivity solutions.
Fabry disease can be detected using a new magnetic resonance imaging (MRI) technique that was developed at the University of Alberta. The discovery of this new diagnostic tool has resulted in updated clinical guidelines for the diagnosis and treatment of Fabry disease in Canada.
Infinitt will introduce its new “Communicator” package at RSNA 2013. It is an add-on that ensures immediate communication of critical test results, provides peer review and emergency room discrepancy management and includes an embedded communication feature that allows real-time collaboration between users of the Infinitt picture archive and communications system (PACS). This is particularly valuable for clarification between the study’s dictating physician and transcriptionist or the referring physician.
Hologic, Inc., a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, announced that Jack W. Cumming, Hologic's president and CEO, presided over the NASDAQ Stock Market Opening Bell Ceremony on Oct. 1, marking the start of a month-long effort to raise awareness of breast cancer and the importance of breast cancer screening. This is the eighth year that Hologic has been selected to participate in the NASDAQ opening bell ceremonies celebrating the start of Breast Cancer Awareness Month.
The North Shore-LIJ Health System Department of Radiation Medicine presented a study to evaluate the reliability of different systems used by caregivers to assess toxicity for patients receiving radiation therapy at the 55th Annual Meeting of the American Society of Therapeutic Radiation Oncology (ASTRO).
Civco Medical Solutions demonstrated the integration between the Protura Robotic Patient Positioning System and Varian’s Clinac iX and Trilogy medical linear accelerators via the Varian Motion Management Interface at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Proton therapy is the most advanced radiation technique available. Unfortunately, access to proton therapy is limited due to the low number of proton therapy centers. Research institutes and hospitals are now frequently investing in proton therapy to make it more accessible to patients.
Results of EORTC trial 10853 appearing in Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcinoma in situ (DCIS). In the European Organisation for Research and Treatment of Cancer (EORTC) study, adjuvant radiotherapy after local excision reduced the incidence of both in situ and invasive local recurrences by a factor of two and resulted in an overall lower risk of mastectomy.